The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 145.00
Bid: 143.00
Ask: 145.00
Change: 0.50 (0.35%)
Spread: 2.00 (1.399%)
Open: 145.00
High: 145.00
Low: 145.00
Prev. Close: 144.50
RCN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Schedule 1 - Redcentric plc

18 Nov 2013 13:00

RNS Number : 2942T
AIM
18 November 2013
 



ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

COMPANY NAME:

Redcentric plc ("Redcentric" or the "Company")

 

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :

Newton House

Cambridge Business Park

Cowley Road

Cambridge

CB4 0WZ

 

COUNTRY OF INCORPORATION:

United Kingdom

 

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

www.redcentricplc.com

 

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

Immediately prior to admission, Redcentric will acquire InTechnology Managed Services Limited ("InTechnology"). Following admission, the business of the Enlarged Group will be that of both Redcentric and InTechnology. Admission will be by way of a reverse takeover due to the size of the transaction.

 

Redcentric comprises the network-based Managed Services business which has been demerged from Redstone plc. Redcentric delivers ICT solutions and services tailored to meet clients' needs; its offering is differentiated by its proprietary networks, creating a genuine end-to-end client service proposition. Redcentric benefits from an established reputation for delivering robust and reliable mid-market Managed Services solutions while focusing on maintaining flexibility to meet customer requirements. The services Redcentric delivers include:

 

(i) designing, implementing, securing and maintaining ICT networks; (ii) hosting services, software and data in the Cloud; and (iii)managing the ICT environment utilised in the delivery of the services, software and data.

 

Redcentric's main country of operation is the United Kingdom.

 

InTechnology, a wholly owned subsidiary of InTechnology plc, is also a Network-Based Managed Services business, providing Cloud services including:

 

(i) network services: from straightforward point-to-point connectivity to full network design and redesign; (ii) hosting services: including colocation with secure 24/7 monitored rack space and a complete wrap-around service; (iii) data services: InTechnology offers online replication, backup, archiving and cloud storage services; (iv) voice services: such as calls and lines, SIP trunking, cloud telephony, call recording and unified communications; and (v) software services: including NetDocuments, Microsoft SharePoint, SQL and Exchange solutions.

 

The Enlarged Group will have an expected combined estate of four major data centres with 1,255 racks and a client base of over 2,000 companies.

 

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

142,377,120 ordinary shares of 0.1 pence each

 

No restrictions as to transfer

 

CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

 

£64 million of capital to be raised on Admission

 

Anticipated market capitalisation on Admission: £113.9 million

 

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

Approximately 28.6 per cent.

 

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM COMPANY HAS APPLIED OR AGREED TO HAVE ANY OF ITS SECURITIES (INCLUDING ITS AIM SECURITIES) ADMITTED OR TRADED:

Not applicable

 

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

Anthony (Tony) Charles Weaver - Chief Executive Officer

Peter John Hallett - Chief Financial Officer

Fraser St.John Fisher - Chief Operating Officer

Richard Alexander McGregor Ramsay - Non-Executive Chairman

David Graham Payne - Non-Executive Director

Andrew Ian Smith - Non-Executive Director

 

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

Name

Number of Existing Ordinary Shares

% of the Existing Ordinary Shares

Number of Ordinary Shares on Admission

% of the Enlarged Share Capital on Admission

Henderson Global Investors

14,397,352

23.08%

30,022,352

21.09%

MXC Capital*

8,561,608

13.73%

10,249,108

7.20%

BlackRock

3,953,305

6.34%

10,203,305

7.17%

Kestrel Partners

5,925,218

9.50%

9,425,218

6.62%

Quantum Partners LP

-

-

9,375,000

6.58%

Eugenia II Investment Holdings Ltd

-

-

7,812,500

5.49%

Hargreave Hale

2,545,540

4.08%

7,545,540

5.30%

Legal & General

6,022,500

9.65%

6,022,500

4.23%

Harwood Capital

-

-

5,000,000

3.51%

Liontrust

-

-

5,000,000

3.51%

Investec

-

-

4,625,000

3.25%

 

* Ian Smith and Tony Weaver are directors and shareholders of MXC Capital and this figure includes 625,000 Ordinary

Shares held in Ian Smith's self-invested personal pension plan.

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

Not applicable

 

(i) ANTICIPATED ACCOUNTING REFERENCE DATE

(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

(i) 31 March

(ii) 31st March 2013

(iii) 31st December 2013, 30 September 2014 and 31 December 2014

 

EXPECTED ADMISSION DATE:

6 December 2013

 

NAME AND ADDRESS OF NOMINATED ADVISER:

Nplus1 Singer Advisory LLP

One Bartholomew Lane

London

EC2N 2AX

 

NAME AND ADDRESS OF BROKER:

Nplus1 Singer Advisory LLP

One Bartholomew Lane

London

EC2N 2AX

 

finnCap

60 New Broad Street

London

EC2M 1JJ

 

OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

 

www.redcentricplc.com

This website will contain full details about Redcentric and the admission of its ordinary shares to trading on AIM.

 

DATE OF NOTIFICATION:

18 November 2013

 

NEW/ UPDATE:

New

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PAABPBTTMBJBBFJ
Date   Source Headline
19th Apr 20241:30 pmRNSHolding(s) in Company
5th Apr 20247:00 amRNSExercise of Options
20th Mar 202412:30 pmRNSExercise of Options
4th Mar 20244:00 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 202412:30 pmRNSDirectorate Change
30th Jan 20244:30 pmRNSDirector/PDMR Shareholding
25th Jan 20244:45 pmRNSDirector/PDMR Shareholding
24th Jan 20246:20 pmRNSExercise of Options
23rd Jan 20244:32 pmRNSDirector/PDMR Shareholding
19th Jan 20247:00 amRNSShare issue in connection with the FY23 Dividend
17th Jan 20245:00 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
11th Jan 20249:45 amRNSDirector/PDMR Shareholding
8th Jan 20244:00 pmRNSDirector/PDMR Shareholding
4th Jan 20241:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20249:00 amRNSDirector/PDMR Shareholding
29th Dec 20237:00 amRNSExercise of Options
27th Dec 20233:30 pmRNSDirector/PDMR Shareholding
20th Dec 202312:00 pmRNSDirector/PDMR Shareholding
18th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20237:00 amRNSExercise of Options
11th Dec 202311:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSDirector/PDMR Shareholding
22nd Nov 20237:00 amRNSDirectorate Change
22nd Nov 20237:00 amRNSHalf Year Results
20th Oct 20231:23 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSExercise of Options
3rd Oct 20237:00 amRNSSave As You Earn Share Option Scheme
28th Sep 20234:00 pmRNSResult of AGM
20th Sep 20234:08 pmRNSGrant of Options and Director/PDMR Shareholding
4th Sep 20237:00 amRNSPublication of Annual Report and Notice of AGM
24th Aug 20237:00 amRNSPreliminary results announcement FY23
17th Aug 20237:00 amRNSNotice of Results
17th Jul 20237:00 amRNSUpdate on Annual Results
28th Apr 20235:08 pmRNSHolding(s) in Company
25th Apr 20237:01 amRNSDirectorate Change
25th Apr 20237:00 amRNSTrading Update
31st Mar 20233:14 pmRNSHolding(s) in Company
22nd Feb 20237:00 amRNSExercise of Options
8th Feb 20237:00 amRNSExercise of Options
11th Jan 20237:00 amRNSExercise of Options
30th Dec 20227:00 amRNSExercise of Options
12th Dec 20227:00 amRNSExercise of Options
8th Dec 20227:00 amRNSHalf Year Results
29th Nov 20223:09 pmRNSHolding(s) in Company
17th Nov 20222:46 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.